Anna Schwartz to Risk Assessment
This is a "connection" page, showing publications Anna Schwartz has written about Risk Assessment.
Connection Strength
0.107
-
Lam AC, Li Y, Brown MC, Deng Y, Hueniken K, Leighl NB, Shepherd FA, Murison K, Wang Z, Kothari J, Wenzlaff AS, Liu H, Kohno T, Pesatori AC, Harris C, Ma H, Dai J, Barnett MJ, Diver R, Leal LF, Fernandez-Tardon G, P?rez-R?os M, Davies MP, Holleczek B, Brennan P, Zaridze D, Holcatova I, Lissowska J, Swiatkowska B, Mates D, Savic M, Brenner H, Andrew AS, Taylor F, Field JK, Ruano-Ravina A, Shete SS, Tardon A, Wang Y, Marchand LL, Reis RM, Schabath MB, Neuhouser ML, Shen H, Landi MT, Shiraishi K, Zhang J, Schwartz AG, Tsao MS, Christiani DC, Yang P, Hung RJ, Xu W, Liu G. Evaluating eight smoking metrics for modelling survival in non-small cell lung cancer. Cancer Epidemiol. 2026 Jun; 102:103052.
Score: 0.048
-
Blackford AL, Childs EJ, Porter N, Petersen GM, Rabe KG, Gallinger S, Borgida A, Syngal S, Cote ML, Schwartz AG, Goggins MG, Hruban RH, Parmigiani G, Klein AP. A risk prediction tool for individuals with a family history of breast, ovarian, or pancreatic cancer: BRCAPANCPRO. Br J Cancer. 2021 12; 125(12):1712-1717.
Score: 0.035
-
Moorman PG, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Peters ES, Schwartz AG, Terry P, Crankshaw S, Wang F, Schildkraut JM. Reproductive factors and ovarian cancer risk in African-American women. Ann Epidemiol. 2016 09; 26(9):654-62.
Score: 0.024